ロード中...
Increased Efficacy of Histone Methyltransferase G9a Inhibitors Against MYCN-Amplified Neuroblastoma
Targeted inhibition of proteins modulating epigenetic changes is an increasingly important priority in cancer therapeutics, and many small molecule inhibitors are currently being developed. In the case of neuroblastoma (NB), a pediatric solid tumor with a paucity of intragenic mutations, epigenetic...
保存先:
| 出版年: | Front Oncol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7269128/ https://ncbi.nlm.nih.gov/pubmed/32537432 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00818 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|